Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: Implications for atherogenesis-Reference-Cited by-同舟云学术

Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: Implications for atherogenesis

Published:2010-06 Issue:2 Volume:210 Page:400-406
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Barillari Giovanni,Iovane André,Bonuglia Margherita,Albonici Loredana,Garofano Paolo,Di Campli Emanuela,Falchi Mario,Condò Ivano,Manzari Vittorio,Ensoli Barbara

Funder

Italian Ministries of Health and Research

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Ensoli B, Sgadari C, Barillari G, Monini P. The fibroblast growth factors. In: Thomson A, Lotze M, (Eds.), The Cytokine Handbook (IV Edition, Chapter 31). London; 2003. pp. 747–781.

2. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation;Francis;Circ Res,2003

3. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries;Hughes;Cardiovasc Res,1993

4. Localization of bFGF in human transplant coronary atherosclerosis;Isik;Ann N Y Acad Sci,1991

5. Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes;Pakala;Cardiovasc Radiat Med,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies;Life;2023-04-12

2. Analysis of Time Series Gene Expression and DNA Methylation Reveals the Molecular Features of Myocardial Infarction Progression;Frontiers in Cardiovascular Medicine;2022-06-24

3. Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases;Journal of Cellular Physiology;2021-02-26

4. Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review);International Journal of Molecular Medicine;2020-02-20

5. Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients;Clinical Journal of the American Society of Nephrology;2018-03-08